Evidence map›Paper›PMID 20100808›Full record

Trial reportNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2010

A tailored intervention to support pharmacy-based counseling for smoking cessation.

Beth C Bock, Karen S Hudmon, James Christian, Amanda L Graham, Frederick R Bock

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03597607 (Efficacy and Cost-Effectiveness of an Intensive and Abbreviated Individualized Smoking Cessation Support Program Delivered by Pharmacists), which is not on this map. Cited by 27 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 10 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03597607 nacompletednot on this mapstarted 2018, after this paper: background citation

Efficacy and Cost-Effectiveness of an Intensive and Abbreviated Individualized Smoking Cessation Support Program Delivered by Pharmacists: A Randomized Controlled Trial

TypeinterventionalSponsorMemorial University of NewfoundlandRan2018 to 2022Enrolled150ConditionsSmoking Cessation, Smoking, Tobacco, Quality of LifeArmsIntensive Smoking Cessation Group, Abbreviated Smoking Cessation Group
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 10 syntheses or guidelines pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Community pharmacy personnel interventions for smoking cessation.The Cochrane database of systematic reviews · 2019
    Pooled it
  5. Pooled it
  6. Nicotine replacement therapy versus control for smoking cessation.The Cochrane database of systematic reviews · 2018
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Interventions for recruiting smokers into cessation programmes.The Cochrane database of systematic reviews · 2012
    Pooled it
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Beth C BockCenter for Behavioral and Preventive Medicine, The Miriam Hospital, Coro Building East, 167 Point Street, Providence, RI 02903, USA. bbock@lifespan.org
Karen S Hudmon
James Christian
Amanda L Graham
Frederick R Bock
American Legacy Foundation · USMiriam Hospital · USUniversity of Indianapolis · US

Funding

Computer Support for Pharmacy-Based Smoking CessationR44DA022167 · NIDA · BOCK TO THE FUTURE, INC · PI BOCK, FREDERICK R · 2006 to 2007
$891k
Computer Support for Pharmacy Based Smoking CessationR43CA099881 · NCI · BOCK TO THE FUTURE, INC · PI BOCK, FREDERICK R · 2003 to 2003
$136k
NCI NIH HHS CA099881NCI NIH HHS R43 CA099881NIDA NIH HHS DA022167NIDA NIH HHS R44 DA022167
6 · The paper itself

Abstract

introductionPharmacists are uniquely positioned within the community to provide smoking cessation counseling to their patients. However, pharmacists experience significant barriers to providing counseling, including limited time, reimbursement, and training in counseling techniques. We tested a computer-driven software system, "Exper_Quit" (EQ), that provided individually tailored interventions to patients who smoke and matching tailored reports for pharmacists to help guide cessation counseling.

methodsA two-phase design was used to recruit an observation-only group (OBS; n = 100), followed by participants (n = 200) randomly assigned to receive either EQ-assisted pharmacist counseling or EQ plus 8 weeks of nicotine transdermal patch (EQ+). Both treatment groups were scheduled to receive two follow-up counseling calls from pharmacists.

resultsMost participants in the EQ and EQ+ groups reported receiving counseling from a pharmacist, including follow-up calls, while none of the OBS participants reported speaking with the pharmacist about cessation. At 6 months, fewer OBS participants reported a quit attempt (42%) compared with EQ (76%) or EQ+ (65%) participants (p < .02). At 6 months, 7-day point-prevalence abstinence was 28% and 15% among the EQ+ and EQ groups, respectively, compared with 8% among OBS participants (p < .01), and EQ+ participants were twice as likely to be quit than were EQ participants (p < .01). DISCUSSION: A tailored software system can facilitate the delivery of smoking cessation counseling to pharmacy patients. Results suggest that EQ was successful in increasing (a) the delivery of cessation counseling, (b) quit attempts, and (c) quit rates. Pharmacists can play an important role in the effective delivery of smoking cessation counseling.

Indexed as

PharmaciesPharmacistsAdultCounselingFemaleHealth PromotionHumansMaleMiddle AgedSmoking Cessation

Identifiers

PMID20100808
PMCPMC2825100
OpenAlexW2004691852

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.